Transparency, Openness and Peer Review
When BMC was founded 20 years ago, a lot was different. The open access (OA) movement was still in its infancy, the digital movement towards both the production…Read more »
When BMC was founded 20 years ago, a lot was different. The open access (OA) movement was still in its infancy, the digital movement towards both the production…Read more »
Posted on behalf of Ru Bains, assistant editor for Genome Medicine Breast cancer is the most common cancer in women worldwide, and it is the second most common…Read more »
Head and neck cancer is the sixth most common cancer worldwide, and head and neck squamous cell carcinoma (HNSCC) is the most frequent form. Certain subtypes of…Read more »
Later this year, Genome Medicine will publish a special issue on the topic of Single cell analysis: into the clinic. This issue will highlight the rapid…Read more »
Anti-inflammatory drugs are taken for many conditions including asthma, rheumatoid arthritis and colitis. The most common class of these drugs, glucocorticoids,…Read more »
To round off our series on the Metabolomics of disease, Genome Medicine’s Editor, Rebecca Furlong, talks to leading scientists Tim Veenstra, David Wishart and…Read more »
Debates rage over why multiple large-scale studies to uncover risk factors for stroke have so far explained only a tiny proportion of inherited stroke cases and…Read more »
Efforts to predict and monitor drug response in individuals and in the population have increased markedly over the past few years, but there is a need for…Read more »
What is metabolomics and how is it being used to predict and manage disease? That’s the subject of Genome Medicine‘s and BioMed Central’s first…Read more »
Hepatocellular carcinoma is the third highest cause of cancer-related death world-wide. Although several treatments are available – and many more are…Read more »